Rotavirus vaccine 116E - Bharat Biotech
Alternative Names: 116E - Bharat Biotech; Oral Rotavirus Vaccine 116E Live Attenuated - Bharat Biotech; ORV-116E; Rotavac; Rotavac - Bharat Biotech; ROTAVAC 5C; ROTAVAC 5C -F1; ROTAVAC 5C -F2; ROTAVAC 5CM; ROTAVAC 5D®; ROTAVAC®-20; Vero cell-based 116E neonatal rotavirus vaccine - Bharat BiotechLatest Information Update: 16 Jan 2024
At a glance
- Originator Bharat Biotech
- Class Rotavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Rotavirus infections
Most Recent Events
- 07 Jul 2023 Phase-III clinical trials in Rotavirus infections (In infants, Prevention) in Chile (PO) (NCT06200844)
- 24 Aug 2022 Launched for Rotavirus infections (In children, Prevention) in Nigeria (PO)
- 16 Apr 2021 Launched for Rotavirus infections (In infants, Prevention) in Vietnam (PO) prior to April 2021